This exchange-traded fund focuses its investments on U. S.-listed companies that offer products or services aimed at protecting against, enduring, or recovering from biological threats to human health. Its portfolio manager strives to allocate nearly all of the fund's capital to the specific securities that comprise its benchmark index.